ID A0A089XDV6_STRGA Unreviewed; 1095 AA.
AC A0A089XDV6;
DT 26-NOV-2014, integrated into UniProtKB/TrEMBL.
DT 26-NOV-2014, sequence version 1.
DT 27-MAR-2024, entry version 41.
DE SubName: Full=Putative glycosyl hydrolase, family 2 {ECO:0000313|EMBL:AIS02193.1};
GN ORFNames=SGLAU_31295 {ECO:0000313|EMBL:AIS02193.1};
OS Streptomyces glaucescens.
OC Bacteria; Actinomycetota; Actinomycetes; Kitasatosporales;
OC Streptomycetaceae; Streptomyces.
OX NCBI_TaxID=1907 {ECO:0000313|EMBL:AIS02193.1, ECO:0000313|Proteomes:UP000029482};
RN [1] {ECO:0000313|Proteomes:UP000029482}
RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC STRAIN=DSM 40922 / GLA O {ECO:0000313|Proteomes:UP000029482};
RX PubMed=25499805; DOI=10.1016/j.jbiotec.2014.11.036;
RA Ortseifen V., Winkler A., Albersmeier A., Wendler S., Puhler A.,
RA Kalinowski J., Ruckert C.;
RT "Complete genome sequence of the actinobacterium Streptomyces glaucescens
RT GLA.O (DSM 40922) consisting of a linear chromosome and one linear
RT plasmid.";
RL J. Biotechnol. 194:81-83(2015).
CC -!- SIMILARITY: Belongs to the glycosyl hydrolase 2 family.
CC {ECO:0000256|ARBA:ARBA00007401}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; CP009438; AIS02193.1; -; Genomic_DNA.
DR RefSeq; WP_043505868.1; NZ_CP009438.1.
DR AlphaFoldDB; A0A089XDV6; -.
DR STRING; 1907.SGLAU_31295; -.
DR KEGG; sgu:SGLAU_31295; -.
DR eggNOG; COG3250; Bacteria.
DR HOGENOM; CLU_009935_0_0_11; -.
DR OrthoDB; 9762066at2; -.
DR Proteomes; UP000029482; Chromosome.
DR GO; GO:0004553; F:hydrolase activity, hydrolyzing O-glycosyl compounds; IEA:InterPro.
DR GO; GO:0005975; P:carbohydrate metabolic process; IEA:InterPro.
DR Gene3D; 2.60.120.200; -; 1.
DR Gene3D; 2.60.120.260; Galactose-binding domain-like; 1.
DR Gene3D; 3.20.20.80; Glycosidases; 1.
DR Gene3D; 2.60.40.10; Immunoglobulins; 1.
DR Gene3D; 3.90.182.10; Toxin - Anthrax Protective Antigen;domain 1; 1.
DR InterPro; IPR036156; Beta-gal/glucu_dom_sf.
DR InterPro; IPR013320; ConA-like_dom_sf.
DR InterPro; IPR008979; Galactose-bd-like_sf.
DR InterPro; IPR006103; Glyco_hydro_2_cat.
DR InterPro; IPR006102; Glyco_hydro_2_Ig-like.
DR InterPro; IPR006104; Glyco_hydro_2_N.
DR InterPro; IPR017853; Glycoside_hydrolase_SF.
DR InterPro; IPR013783; Ig-like_fold.
DR InterPro; IPR006558; LamG-like.
DR InterPro; IPR037524; PA14/GLEYA.
DR InterPro; IPR011658; PA14_dom.
DR InterPro; IPR006311; TAT_signal.
DR PANTHER; PTHR42732; BETA-GALACTOSIDASE; 1.
DR PANTHER; PTHR42732:SF2; BETA-MANNOSIDASE; 1.
DR Pfam; PF00703; Glyco_hydro_2; 1.
DR Pfam; PF02836; Glyco_hydro_2_C; 1.
DR Pfam; PF02837; Glyco_hydro_2_N; 1.
DR Pfam; PF13385; Laminin_G_3; 1.
DR Pfam; PF07691; PA14; 1.
DR SMART; SM00560; LamGL; 1.
DR SMART; SM00758; PA14; 1.
DR SUPFAM; SSF51445; (Trans)glycosidases; 1.
DR SUPFAM; SSF56988; Anthrax protective antigen; 1.
DR SUPFAM; SSF49303; beta-Galactosidase/glucuronidase domain; 1.
DR SUPFAM; SSF49899; Concanavalin A-like lectins/glucanases; 1.
DR SUPFAM; SSF49785; Galactose-binding domain-like; 1.
DR PROSITE; PS51820; PA14; 1.
DR PROSITE; PS51318; TAT; 1.
PE 3: Inferred from homology;
KW Glycosidase {ECO:0000256|ARBA:ARBA00023295};
KW Hydrolase {ECO:0000256|ARBA:ARBA00022801, ECO:0000313|EMBL:AIS02193.1};
KW Reference proteome {ECO:0000313|Proteomes:UP000029482};
KW Signal {ECO:0000256|ARBA:ARBA00022729, ECO:0000256|SAM:SignalP}.
FT SIGNAL 1..29
FT /evidence="ECO:0000256|SAM:SignalP"
FT CHAIN 30..1095
FT /evidence="ECO:0000256|SAM:SignalP"
FT /id="PRO_5039583057"
FT DOMAIN 55..199
FT /note="PA14"
FT /evidence="ECO:0000259|PROSITE:PS51820"
FT REGION 313..334
FT /note="Disordered"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ SEQUENCE 1095 AA; 118984 MW; F1212301EE1C855E CRC64;
MTTRHTRRRT TLWALLTAAA LVLPTPGLTA TASATASAAE TSGGAPGLPV REAAAAVHGL
KGEYFRMSAP GARDFAESGG TLLDPQINFS DLTGTFQELT GRTEHTTARW TGRIEPPVTG
DYTFHAIGDN GFRLYIDGEP VIDHWVGDWD REQTSAPVTL TAGERHDFRL EMFQDTGGAG
MFLRWSAPGL PKQLVPQSAF TPPDGFEVYP VEPSVSGNGR QVRARFEGDL GGDTGTVAGH
LKIEADTTAM PIAGAAVAPG DPRSLLVTLA APIQKGQQVR LTYDGTGGLT SGGETVPRII
RWARNDSTHR LTTPWGDKLD ERNPLPEYPR PQQVRSRWKN LNGPWQFSGA APGERPVFGK
DLDERIIVPF PVESQLSGIE RHEDHMFYRR LVDVPKSWNV GTGGDGNRLV LNFGAVDHRA
RVWVNGRQVT EHTGGYTAFS ADVTDALERT GPQEIVVAVT DTGGADQPKG KQSTHPGGIF
YTQSSGIWQT VWMEPVARTS IDDIVTTPDI DSARLALTVE SDDASPAARV EAVARDARGR
VVGRTSGPAN RELRLPVADQ HLWSPDDPYL YDLDVRLIDG RSTDRAGSYF GMREIGVEKV
GGFRKLVLNG EPVFSLATLD QGFWPDGLYT PPSDAALAFD LKAHKRLGFN AVRKHIKVES
PRWFHHADRL GLLVWQDFVS GDLTSDTGRA AFVDQGLETV RQHRSSPSVI GWVVFNEGWG
EWNREESGRL AETVKAADPS RVVNAHSGVN CCNSKGDSGK GDIIDHHDYN NDDPPFPDHR
AAMDGEHGGF TLRTPGHMWP GAPTVIYSGV EDKEALTRTY VENTEKYYLD QAAHELSGSV
YTQITDLENE LNGLYTYDRR QIKVDPVRVR EINLRVIAAG AAAGERGNLE GGGHWALDEG
TGGTARDDGP NGEPLTLTGG TTWTAGIDGS ALRFDGRGQY ARTDGPVLDT TAGYSVSAWV
TLDSLPENYA TAVSQDTRRR AGPFYLQYGR GAFAFSTPGE HRARLEITPE TGRWYHLVGV
RDSASDEIRL YVDGVPAATA KAGPAYPSTG PFTVGRAQWD GAHADFWDGA VDEVHAFDRA
LTAAEVSALH ARQKP
//